08:06 AM EDT, 04/26/2024 (MT Newswires) -- AbbVie ( ABBV ) reported Q1 adjusted earnings Friday of $2.31 per diluted share, down from $2.46 a year earlier.

Analysts polled by Capital IQ expected $2.26.

Net revenue for the quarter ended March 31 was $12.31 billion, up from $12.23 billion a year earlier.

Analysts surveyed by Capital IQ expected $11.94 billion.

The drugmaker said it now expects 2024 adjusted diluted EPS in the range of $11.13 to $11.33, up from its prior range of $10.97 to $11.17. Analysts polled by Capital IQ expect $11.12.

Shares of the company were up less than 1% in recent Friday premarket activity.

Price: 169.17, Change: +1.88, Percent Change: +1.12